Skip to main content
. 2018 Apr 3;9(25):17554–17563. doi: 10.18632/oncotarget.24785

Table 3. Tumor response rate in NSCLC patients.

Type of treatment PD-L1 status ORR-N (%) p-value
CR + PR SD + PD
All treatment PD-L1 positive 10 (43.5) 13 (56.5) 0.87
PD-L1 negative 11 (45.8) 13 (54.2)
Chemotherapy PD-L1 positive 8 (47.1) 9 (52.9) 0.73
PD-L1 negative 6 (40.0) 9 (60.0)
No chemotherapy PD-L1 positive 2 (33.3) 4 (66.7) 0.60
PD-L1 negative 5 (55.6) 4 (44.4)

ORR = overall response rate; CR = complete response; PR = partial response; SD = stable disease; PD = progression disease.